Description

Solid Lipid Nanoparticles (SLNs) Drug Delivery System is a carrier platform composed of solid lipid cores stabilized by surfactants, enabling efficient encapsulation and controlled release of therapeutic compounds. The solid lipid matrix provides structural stability while protecting encapsulated drugs from degradation, improving bioavailability and delivery efficiency.

The system supports a wide range of therapeutics, including hydrophobic and sensitive molecules. Particle size, lipid composition, and formulation parameters can be tuned to control release kinetics and targeting behavior. The formulation is optimized for reproducibility and compatibility with pharmaceutical and biomedical applications, offering a robust alternative to traditional delivery systems.

Key features
Solid lipid core structure
Enhanced drug stability and protection
Controlled and sustained release
Tunable particle size and composition
High biocompatibility

Typical specifications
Volume 20 mL
Structure solid lipid nanoparticles
Size range 50–300 nm (customizable)
Encapsulation compatible with hydrophobic drugs
Sterility available upon request

Applications
Drug delivery systems
Cancer therapeutics
Oral and topical formulations
Targeted delivery research
Nanomedicine development